Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vickerman

Showing results (381-390 of 397) with videos related to

Pageof 40
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 10, 2021
Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020 - is the precautionary principle applicable?Lucas Wiessing, Eleni Kalamara, Jack Stone, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2024
Comparison of Empirically Derived and Model-Based Estimates of Key Population HIV Incidence and the Distribution of New Infections by Population Group in Sub-Saharan AfricaOliver Stevens, Rebecca Anderson, John Stover, et al.
The International Journal on Drug Policy|January 6, 2026
Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
The Lancet. Global Health|December 23, 2019
Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling studyJosephine G Walker, Tinatin Kuchuloria, David Sergeenko, et al.
Harm Reduction Journal|April 23, 2017
Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus studyLucas Wiessing, Marica Ferri, Vendula Běláčková, et al.
Lancet (London, England)|March 24, 2024
Under threat: the International AIDS Society-Lancet Commission on Health and Human RightsChris Beyrer, Adeeba Kamarulzaman, Michael Isbell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2024
Measuring HIV Acquisitions Among Partners of Key Populations: Estimates From HIV Transmission Dynamic ModelsRomain Silhol, Rebecca L Anderson, Oliver Stevens, et al.
The Lancet. HIV|June 25, 2026
Cost-effectiveness of emergency department opt-out testing for HIV in England: a modelling studyJosephine G Walker, Rebecca F Baggaley, Gareth Myring, et al.
The Lancet. Gastroenterology & Hepatology|March 30, 2023
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysisAdelina Artenie, Jack Stone, Hannah Fraser, et al.
Journal of the International AIDS Society|March 10, 2026
Integrating HIV services in an era of global changeJirair Ratevosian, Linda-Gail Bekker, Robyn Eakle, et al.
Pageof 40

Showing results (381-390 of 397) with videos related to

Sort By:
Pageof 40
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 10, 2021
Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020 - is the precautionary principle applicable?Lucas Wiessing, Eleni Kalamara, Jack Stone, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2024
Comparison of Empirically Derived and Model-Based Estimates of Key Population HIV Incidence and the Distribution of New Infections by Population Group in Sub-Saharan AfricaOliver Stevens, Rebecca Anderson, John Stover, et al.
The International Journal on Drug Policy|January 6, 2026
Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
The Lancet. Global Health|December 23, 2019
Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling studyJosephine G Walker, Tinatin Kuchuloria, David Sergeenko, et al.
Harm Reduction Journal|April 23, 2017
Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus studyLucas Wiessing, Marica Ferri, Vendula Běláčková, et al.
Lancet (London, England)|March 24, 2024
Under threat: the International AIDS Society-Lancet Commission on Health and Human RightsChris Beyrer, Adeeba Kamarulzaman, Michael Isbell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2024
Measuring HIV Acquisitions Among Partners of Key Populations: Estimates From HIV Transmission Dynamic ModelsRomain Silhol, Rebecca L Anderson, Oliver Stevens, et al.
The Lancet. HIV|June 25, 2026
Cost-effectiveness of emergency department opt-out testing for HIV in England: a modelling studyJosephine G Walker, Rebecca F Baggaley, Gareth Myring, et al.
The Lancet. Gastroenterology & Hepatology|March 30, 2023
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysisAdelina Artenie, Jack Stone, Hannah Fraser, et al.
Journal of the International AIDS Society|March 10, 2026
Integrating HIV services in an era of global changeJirair Ratevosian, Linda-Gail Bekker, Robyn Eakle, et al.
Pageof 40